new_0222_0299|ALGS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0299|ALGS|1|Aligos Therapeutics Inc Total Current Assets (Quarterly) (USD)|Aligos Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Aligos Therapeutics Inc Inventories (Quarterly) (USD)|Aligos Therapeutics Inc Net PP&E (Quarterly) (USD)|Aligos Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Aligos Therapeutics Inc Total Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Deposits (Quarterly) (USD)|Aligos Therapeutics Inc Book Value (Quarterly) (USD)|Aligos Therapeutics Inc Retained Earnings (Quarterly) (USD)|Aligos Therapeutics Inc Treasury Stock (Quarterly) (USD)|Aligos Therapeutics Inc EV to Revenues|Aligos Therapeutics Inc EV to Earnings|Aligos Therapeutics Inc EV to Free Cash Flow|Aligos Therapeutics Inc EV to Assets (Quarterly)|Aligos Therapeutics Inc PS Ratio|Aligos Therapeutics Inc PE Ratio|Aligos Therapeutics Inc Price to Book Value|Aligos Therapeutics Inc PEG Ratio|Aligos Therapeutics Inc Debt to Equity Ratio|Aligos Therapeutics Inc Dividend Yield|Aligos Therapeutics Inc Shareholder Yield (TTM)|Aligos Therapeutics Inc Percent of Shares Outstanding Short|Aligos Therapeutics Inc Total Receivables (Quarterly) (USD)|Aligos Therapeutics Inc Total Payables (Quarterly) (USD)|Aligos Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Aligos Therapeutics Inc Return on Invested Capital|Aligos Therapeutics Inc Quality Ratio Score|Aligos Therapeutics Inc Momentum Score|Aligos Therapeutics Inc Beta (1Y)|Aligos Therapeutics Inc Sustainable Growth Rate (TTM)|Aligos Therapeutics Inc Institutional Investor Ownership Percentage|Aligos Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Aligos Therapeutics Inc Total Employees (Annual)|Aligos Therapeutics Inc EPS Diluted (Quarterly) (USD)|Aligos Therapeutics Inc Shares Outstanding|Aligos Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Aligos Therapeutics Inc Ordinary Shares Number (Quarterly)|Aligos Therapeutics Inc Payout Ratio|Aligos Therapeutics Inc Quick Ratio (Quarterly)|Aligos Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Aligos Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Aligos Therapeutics Inc Effective Tax Rate (TTM)|Aligos Therapeutics Inc Return on Equity|Aligos Therapeutics Inc Net Income (TTM) (USD)|Aligos Therapeutics Inc Revenue (TTM) (USD)|Aligos Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Aligos Therapeutics Inc Revenue (Quarterly) (USD)|Aligos Therapeutics Inc Gross Profit (Quarterly) (USD)|Aligos Therapeutics Inc SG&A Expense (Quarterly) (USD)|Aligos Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Aligos Therapeutics Inc Net Income (Quarterly) (USD)|Aligos Therapeutics Inc Net Interest Income (Quarterly) (USD)|Aligos Therapeutics Inc Price (USD)|Aligos Therapeutics Inc Total Return Price (USD)|Aligos Therapeutics Inc Enterprise Value (USD)|Aligos Therapeutics Inc 30-Day Average Daily Volume|Aligos Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0299|ALGS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0299|ALGS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0299|ALGS|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44839857651|91.5|0|0|1.44839857651|0|91.5|1.45045045045|0|15.2666666667|0|106.5|106.5|0|0|31|30.6666666667|0|30.4444444444|91.375|91.4|91.375|29.8461538462|91.3333333333|106.5|0|91.5|91.375|91.25|91.4|0|91.4|0|0|91.5|0|91.375|91.375|91.375|91.375|1.45045045045|1.45045045045|1.45045045045|1.45065789474|1.43209876543||
new_0222_0299|ALGS|6|6|6|0|6|0|6|6|6|0|6|6|0|0|0|281|2|0|0|281|0|2|333|0|30|0|6|6|0|0|2|3|0|9|8|5|8|13|6|6|0|2|8|4|5|0|5|0|0|2|0|8|8|8|8|333|333|333|304|81||
new_0222_0299|ALGS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0299|ALGS|201909||||||||||||||||||||||||||||||||||21.9313||-0.6407||||||-0.6407|||||||||2.775|-14.051|-14.051|0.345|||||||
new_0222_0299|ALGS|201912|120.226|117.663||16.087||211.411|13.818|197.593||-64.891|-66.197|||||||||||||||3.767|0|||||||21.9313||-0.8291|||36.8902|||-0.8291|||||||||3.463|-18.099|-18.184|0.556|||||||
new_0222_0299|ALGS|202003||||||||||||||||||||||||||||||||||21.9313||-0.9133||-0.405||||-0.9133|||||||||3.419|-20.029|-20.029|0.468|||||||
new_0222_0299|ALGS|202006|132.229|128.897||16.212||26.718|15.364|11.354||121.958|-107.023|||||||||||||||3.296|0.002|||||||21.9313|67|-0.9483||0|36.8902|||-0.9483||-0.0356||-73.061|||||4.095|-20.856|-20.797|0.374|||||||
new_0222_0299|ALGS|202009|73.693|70.064||15.646||228.851|19.984|208.867||-136.668|-140.32|||||||||||0||5.2978||7.682|0||||||19.4208|36.8902|73|-0.9026|36.8902|0|36.8902|||-0.9026|0|-0.0282||-92.307|||||4.225|-33.297|-33.297|0.234|14.94|14.94|481.0756|187321.6||18.71|
new_0222_0299|ALGS|202012|250.017|243.513||14.908||45.263|30.274|14.989||220.039|-174.74||||-10.0705||||4.5999|||0||5.3504||3.313|0.004|||||||36.6062|74|-1.09|36.6062|0.405|36.6062|||-1.09|-155.542|-0.1476||-108.543|||||6.205|-34.201|-34.42||27.65|27.65|768.6484|260801.6667||28.17|28.74
new_0222_0299|ALGS|202103|219.826|213.415||14.526||39.32|25.231|14.089||195.22|-202.414||||-7.6928|2.7887|||4.4435||0|0||4.0591||2.81|0.004|||||||37.4343|69|-0.74|38.1472|0|38.1472||8.4584|-0.74||-0.1768||-116.188|||0.91||5.781|-27.629|-27.674|0.105|22.74|22.74|654.0523|59909.5333||25.72|27.88
new_0222_0299|ALGS|202106|196.642|190.653||13.753||42.992|30.098|12.894||168.884|-232.232||||-6.5392|2.7755|||4.6109||0|0||4.4728||1.593|0.004||||||95.7816|37.619|86|-0.79|38.2001|0|38.2001||6.3344|-0.79||-0.2338||-125.209|||1.545||6.556|-29.79|-29.818|0.072|20.385|20.385|588.056|166961.1||14.57|17.05
new_0222_0299|ALGS|202109|248.67|242.185||13.158||46.057|34.78|11.277||217.011|-265.358||||-4.2517|1.5917|||3.0455||0|0||4.4608||2.601|0.004|||4|1.9573|||42.4|86|-0.78|42.6118|0|42.6118||6.9633|-0.78|-78.584|-0.3354||-125.036|||1.537||6.473|-32.998|-33.124|0.02|15.51|15.51|418.724|251853.8667|7.7808|15.93|15.32
new_0222_0299|ALGS|202112|||||||||||||||-2.6773||||2.331|||0||5.2997||||||3|0.1472||||||||||||||||||||||||11.87|11.87|263.6693|205612.6667|-57.0705|3.19|2.58